The global Biopharmaceutical CDMO Service market was valued at US$ 14640 million in 2023 and is anticipated to reach US$ 29770 million by 2030, witnessing a CAGR of 10.3% during the forecast period 2024-2030.

Biopharmaceutical CDMO Service Market

North American market for Biopharmaceutical CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Biopharmaceutical CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Biopharmaceutical CDMO Service in Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Biopharmaceutical CDMO Service include KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma and Catalent, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Biopharmaceutical CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharmaceutical CDMO Service.

Report Scope

The Biopharmaceutical CDMO Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biopharmaceutical CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biopharmaceutical CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Biopharmaceutical CDMO Service Market Report

Report Metric	Details
Report Name	Biopharmaceutical CDMO Service Market
Accounted market size in 2023	US$ 14640 million
Forecasted market size in 2030	US$ 29770 million
CAGR	10.3%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Develop Innovative Drugs Listed Patented Drug Biosimilars Others
Segment by Application	Pharmaceutical Company Biotechnology Company Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma, Catalent, Future Fields, Vetter Pharma, Stelis, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Cambrex, Pfizer CentreOne, Samsung Biologics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biopharmaceutical CDMO Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Biopharmaceutical CDMO Service Market growing?

Ans: The Biopharmaceutical CDMO Service Market witnessing a CAGR of 10.3% during the forecast period 2024-2030.

What is the Biopharmaceutical CDMO Service Market size in 2030?

Ans: The Biopharmaceutical CDMO Service Market size in 2030 will be US$ 29770 million.

Who are the main players in the Biopharmaceutical CDMO Service Market report?

Ans: The main players in the Biopharmaceutical CDMO Service Market are KBI Biopharma, INCOG BioPharma Services, CordenPharma, AGC Biologics, Northway Biotech, PlantForm Corp, Lonza, ADL Biopharma, Catalent, Future Fields, Vetter Pharma, Stelis, Richter-Helm, FUJIFILM Diosynth Biotechnologies, Cambrex, Pfizer CentreOne, Samsung Biologics

What are the Application segmentation covered in the Biopharmaceutical CDMO Service Market report?

Ans: The Applications covered in the Biopharmaceutical CDMO Service Market report are Pharmaceutical Company, Biotechnology Company, Others

What are the Type segmentation covered in the Biopharmaceutical CDMO Service Market report?

Ans: The Types covered in the Biopharmaceutical CDMO Service Market report are Develop Innovative Drugs, Listed Patented Drug, Biosimilars, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Biopharmaceutical CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Develop Innovative Drugs

1.2.3 Listed Patented Drug

1.2.4 Biosimilars

1.2.5 Others

1.3 Market by Application

1.3.1 Global Biopharmaceutical CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Pharmaceutical Company

1.3.3 Biotechnology Company

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Biopharmaceutical CDMO Service Market Perspective (2019-2030)

2.2 Biopharmaceutical CDMO Service Growth Trends by Region

2.2.1 Global Biopharmaceutical CDMO Service Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Biopharmaceutical CDMO Service Historic Market Size by Region (2019-2024)

2.2.3 Biopharmaceutical CDMO Service Forecasted Market Size by Region (2025-2030)

2.3 Biopharmaceutical CDMO Service Market Dynamics

2.3.1 Biopharmaceutical CDMO Service Industry Trends

2.3.2 Biopharmaceutical CDMO Service Market Drivers

2.3.3 Biopharmaceutical CDMO Service Market Challenges

2.3.4 Biopharmaceutical CDMO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Biopharmaceutical CDMO Service Players by Revenue

3.1.1 Global Top Biopharmaceutical CDMO Service Players by Revenue (2019-2024)

3.1.2 Global Biopharmaceutical CDMO Service Revenue Market Share by Players (2019-2024)

3.2 Global Biopharmaceutical CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Biopharmaceutical CDMO Service Revenue

3.4 Global Biopharmaceutical CDMO Service Market Concentration Ratio

3.4.1 Global Biopharmaceutical CDMO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical CDMO Service Revenue in 2023

3.5 Biopharmaceutical CDMO Service Key Players Head office and Area Served

3.6 Key Players Biopharmaceutical CDMO Service Product Solution and Service

3.7 Date of Enter into Biopharmaceutical CDMO Service Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Biopharmaceutical CDMO Service Breakdown Data by Type

4.1 Global Biopharmaceutical CDMO Service Historic Market Size by Type (2019-2024)

4.2 Global Biopharmaceutical CDMO Service Forecasted Market Size by Type (2025-2030)

5 Biopharmaceutical CDMO Service Breakdown Data by Application

5.1 Global Biopharmaceutical CDMO Service Historic Market Size by Application (2019-2024)

5.2 Global Biopharmaceutical CDMO Service Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Biopharmaceutical CDMO Service Market Size (2019-2030)

6.2 North America Biopharmaceutical CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Biopharmaceutical CDMO Service Market Size by Country (2019-2024)

6.4 North America Biopharmaceutical CDMO Service Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Biopharmaceutical CDMO Service Market Size (2019-2030)

7.2 Europe Biopharmaceutical CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Biopharmaceutical CDMO Service Market Size by Country (2019-2024)

7.4 Europe Biopharmaceutical CDMO Service Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Biopharmaceutical CDMO Service Market Size (2019-2030)

8.2 Asia-Pacific Biopharmaceutical CDMO Service Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Biopharmaceutical CDMO Service Market Size by Region (2019-2024)

8.4 Asia-Pacific Biopharmaceutical CDMO Service Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Biopharmaceutical CDMO Service Market Size (2019-2030)

9.2 Latin America Biopharmaceutical CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Biopharmaceutical CDMO Service Market Size by Country (2019-2024)

9.4 Latin America Biopharmaceutical CDMO Service Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Biopharmaceutical CDMO Service Market Size (2019-2030)

10.2 Middle East & Africa Biopharmaceutical CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Biopharmaceutical CDMO Service Market Size by Country (2019-2024)

10.4 Middle East & Africa Biopharmaceutical CDMO Service Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 KBI Biopharma

11.1.1 KBI Biopharma Company Detail

11.1.2 KBI Biopharma Business Overview

11.1.3 KBI Biopharma Biopharmaceutical CDMO Service Introduction

11.1.4 KBI Biopharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.1.5 KBI Biopharma Recent Development

11.2 INCOG BioPharma Services

11.2.1 INCOG BioPharma Services Company Detail

11.2.2 INCOG BioPharma Services Business Overview

11.2.3 INCOG BioPharma Services Biopharmaceutical CDMO Service Introduction

11.2.4 INCOG BioPharma Services Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.2.5 INCOG BioPharma Services Recent Development

11.3 CordenPharma

11.3.1 CordenPharma Company Detail

11.3.2 CordenPharma Business Overview

11.3.3 CordenPharma Biopharmaceutical CDMO Service Introduction

11.3.4 CordenPharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.3.5 CordenPharma Recent Development

11.4 AGC Biologics

11.4.1 AGC Biologics Company Detail

11.4.2 AGC Biologics Business Overview

11.4.3 AGC Biologics Biopharmaceutical CDMO Service Introduction

11.4.4 AGC Biologics Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.4.5 AGC Biologics Recent Development

11.5 Northway Biotech

11.5.1 Northway Biotech Company Detail

11.5.2 Northway Biotech Business Overview

11.5.3 Northway Biotech Biopharmaceutical CDMO Service Introduction

11.5.4 Northway Biotech Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.5.5 Northway Biotech Recent Development

11.6 PlantForm Corp

11.6.1 PlantForm Corp Company Detail

11.6.2 PlantForm Corp Business Overview

11.6.3 PlantForm Corp Biopharmaceutical CDMO Service Introduction

11.6.4 PlantForm Corp Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.6.5 PlantForm Corp Recent Development

11.7 Lonza

11.7.1 Lonza Company Detail

11.7.2 Lonza Business Overview

11.7.3 Lonza Biopharmaceutical CDMO Service Introduction

11.7.4 Lonza Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.7.5 Lonza Recent Development

11.8 ADL Biopharma

11.8.1 ADL Biopharma Company Detail

11.8.2 ADL Biopharma Business Overview

11.8.3 ADL Biopharma Biopharmaceutical CDMO Service Introduction

11.8.4 ADL Biopharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.8.5 ADL Biopharma Recent Development

11.9 Catalent

11.9.1 Catalent Company Detail

11.9.2 Catalent Business Overview

11.9.3 Catalent Biopharmaceutical CDMO Service Introduction

11.9.4 Catalent Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.9.5 Catalent Recent Development

11.10 Future Fields

11.10.1 Future Fields Company Detail

11.10.2 Future Fields Business Overview

11.10.3 Future Fields Biopharmaceutical CDMO Service Introduction

11.10.4 Future Fields Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.10.5 Future Fields Recent Development

11.11 Vetter Pharma

11.11.1 Vetter Pharma Company Detail

11.11.2 Vetter Pharma Business Overview

11.11.3 Vetter Pharma Biopharmaceutical CDMO Service Introduction

11.11.4 Vetter Pharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.11.5 Vetter Pharma Recent Development

11.12 Stelis

11.12.1 Stelis Company Detail

11.12.2 Stelis Business Overview

11.12.3 Stelis Biopharmaceutical CDMO Service Introduction

11.12.4 Stelis Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.12.5 Stelis Recent Development

11.13 Richter-Helm

11.13.1 Richter-Helm Company Detail

11.13.2 Richter-Helm Business Overview

11.13.3 Richter-Helm Biopharmaceutical CDMO Service Introduction

11.13.4 Richter-Helm Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.13.5 Richter-Helm Recent Development

11.14 FUJIFILM Diosynth Biotechnologies

11.14.1 FUJIFILM Diosynth Biotechnologies Company Detail

11.14.2 FUJIFILM Diosynth Biotechnologies Business Overview

11.14.3 FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Introduction

11.14.4 FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.14.5 FUJIFILM Diosynth Biotechnologies Recent Development

11.15 Cambrex

11.15.1 Cambrex Company Detail

11.15.2 Cambrex Business Overview

11.15.3 Cambrex Biopharmaceutical CDMO Service Introduction

11.15.4 Cambrex Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.15.5 Cambrex Recent Development

11.16 Pfizer CentreOne

11.16.1 Pfizer CentreOne Company Detail

11.16.2 Pfizer CentreOne Business Overview

11.16.3 Pfizer CentreOne Biopharmaceutical CDMO Service Introduction

11.16.4 Pfizer CentreOne Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.16.5 Pfizer CentreOne Recent Development

11.17 Samsung Biologics

11.17.1 Samsung Biologics Company Detail

11.17.2 Samsung Biologics Business Overview

11.17.3 Samsung Biologics Biopharmaceutical CDMO Service Introduction

11.17.4 Samsung Biologics Revenue in Biopharmaceutical CDMO Service Business (2019-2024)

11.17.5 Samsung Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

FUJIFILM Diosynth Biotechnologies

Cambrex

Pfizer CentreOne

Samsung Biologics

INCOG BioPharma Services

PlantForm Corp

Future Fields

Stelis

List of Tables

Table 1. Global Biopharmaceutical CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Develop Innovative Drugs

Table 3. Key Players of Listed Patented Drug

Table 4. Key Players of Biosimilars

Table 5. Key Players of Others

Table 6. Global Biopharmaceutical CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Biopharmaceutical CDMO Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Biopharmaceutical CDMO Service Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Biopharmaceutical CDMO Service Market Share by Region (2019-2024)

Table 10. Global Biopharmaceutical CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Biopharmaceutical CDMO Service Market Share by Region (2025-2030)

Table 12. Biopharmaceutical CDMO Service Market Trends

Table 13. Biopharmaceutical CDMO Service Market Drivers

Table 14. Biopharmaceutical CDMO Service Market Challenges

Table 15. Biopharmaceutical CDMO Service Market Restraints

Table 16. Global Biopharmaceutical CDMO Service Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Biopharmaceutical CDMO Service Market Share by Players (2019-2024)

Table 18. Global Top Biopharmaceutical CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO Service as of 2023)

Table 19. Ranking of Global Top Biopharmaceutical CDMO Service Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Biopharmaceutical CDMO Service Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Biopharmaceutical CDMO Service Product Solution and Service

Table 23. Date of Enter into Biopharmaceutical CDMO Service Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Biopharmaceutical CDMO Service Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Biopharmaceutical CDMO Service Revenue Market Share by Type (2019-2024)

Table 27. Global Biopharmaceutical CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Biopharmaceutical CDMO Service Revenue Market Share by Type (2025-2030)

Table 29. Global Biopharmaceutical CDMO Service Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Biopharmaceutical CDMO Service Revenue Market Share by Application (2019-2024)

Table 31. Global Biopharmaceutical CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Biopharmaceutical CDMO Service Revenue Market Share by Application (2025-2030)

Table 33. North America Biopharmaceutical CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Biopharmaceutical CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Biopharmaceutical CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Biopharmaceutical CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Biopharmaceutical CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Biopharmaceutical CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Biopharmaceutical CDMO Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Biopharmaceutical CDMO Service Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Biopharmaceutical CDMO Service Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Biopharmaceutical CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Biopharmaceutical CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Biopharmaceutical CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Biopharmaceutical CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Biopharmaceutical CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 48. KBI Biopharma Company Detail

Table 49. KBI Biopharma Business Overview

Table 50. KBI Biopharma Biopharmaceutical CDMO Service Product

Table 51. KBI Biopharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 52. KBI Biopharma Recent Development

Table 53. INCOG BioPharma Services Company Detail

Table 54. INCOG BioPharma Services Business Overview

Table 55. INCOG BioPharma Services Biopharmaceutical CDMO Service Product

Table 56. INCOG BioPharma Services Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 57. INCOG BioPharma Services Recent Development

Table 58. CordenPharma Company Detail

Table 59. CordenPharma Business Overview

Table 60. CordenPharma Biopharmaceutical CDMO Service Product

Table 61. CordenPharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 62. CordenPharma Recent Development

Table 63. AGC Biologics Company Detail

Table 64. AGC Biologics Business Overview

Table 65. AGC Biologics Biopharmaceutical CDMO Service Product

Table 66. AGC Biologics Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 67. AGC Biologics Recent Development

Table 68. Northway Biotech Company Detail

Table 69. Northway Biotech Business Overview

Table 70. Northway Biotech Biopharmaceutical CDMO Service Product

Table 71. Northway Biotech Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 72. Northway Biotech Recent Development

Table 73. PlantForm Corp Company Detail

Table 74. PlantForm Corp Business Overview

Table 75. PlantForm Corp Biopharmaceutical CDMO Service Product

Table 76. PlantForm Corp Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 77. PlantForm Corp Recent Development

Table 78. Lonza Company Detail

Table 79. Lonza Business Overview

Table 80. Lonza Biopharmaceutical CDMO Service Product

Table 81. Lonza Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 82. Lonza Recent Development

Table 83. ADL Biopharma Company Detail

Table 84. ADL Biopharma Business Overview

Table 85. ADL Biopharma Biopharmaceutical CDMO Service Product

Table 86. ADL Biopharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 87. ADL Biopharma Recent Development

Table 88. Catalent Company Detail

Table 89. Catalent Business Overview

Table 90. Catalent Biopharmaceutical CDMO Service Product

Table 91. Catalent Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 92. Catalent Recent Development

Table 93. Future Fields Company Detail

Table 94. Future Fields Business Overview

Table 95. Future Fields Biopharmaceutical CDMO Service Product

Table 96. Future Fields Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 97. Future Fields Recent Development

Table 98. Vetter Pharma Company Detail

Table 99. Vetter Pharma Business Overview

Table 100. Vetter Pharma Biopharmaceutical CDMO Service Product

Table 101. Vetter Pharma Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 102. Vetter Pharma Recent Development

Table 103. Stelis Company Detail

Table 104. Stelis Business Overview

Table 105. Stelis Biopharmaceutical CDMO Service Product

Table 106. Stelis Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 107. Stelis Recent Development

Table 108. Richter-Helm Company Detail

Table 109. Richter-Helm Business Overview

Table 110. Richter-Helm Biopharmaceutical CDMO Service Product

Table 111. Richter-Helm Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 112. Richter-Helm Recent Development

Table 113. FUJIFILM Diosynth Biotechnologies Company Detail

Table 114. FUJIFILM Diosynth Biotechnologies Business Overview

Table 115. FUJIFILM Diosynth Biotechnologies Biopharmaceutical CDMO Service Product

Table 116. FUJIFILM Diosynth Biotechnologies Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 117. FUJIFILM Diosynth Biotechnologies Recent Development

Table 118. Cambrex Company Detail

Table 119. Cambrex Business Overview

Table 120. Cambrex Biopharmaceutical CDMO Service Product

Table 121. Cambrex Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 122. Cambrex Recent Development

Table 123. Pfizer CentreOne Company Detail

Table 124. Pfizer CentreOne Business Overview

Table 125. Pfizer CentreOne Biopharmaceutical CDMO Service Product

Table 126. Pfizer CentreOne Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 127. Pfizer CentreOne Recent Development

Table 128. Samsung Biologics Company Detail

Table 129. Samsung Biologics Business Overview

Table 130. Samsung Biologics Biopharmaceutical CDMO Service Product

Table 131. Samsung Biologics Revenue in Biopharmaceutical CDMO Service Business (2019-2024) & (US$ Million)

Table 132. Samsung Biologics Recent Development

Table 133. Research Programs/Design for This Report

Table 134. Key Data Information from Secondary Sources

Table 135. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Biopharmaceutical CDMO Service Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Biopharmaceutical CDMO Service Market Share by Type: 2023 VS 2030

Figure 3. Develop Innovative Drugs Features

Figure 4. Listed Patented Drug Features

Figure 5. Biosimilars Features

Figure 6. Others Features

Figure 7. Global Biopharmaceutical CDMO Service Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Biopharmaceutical CDMO Service Market Share by Application: 2023 VS 2030

Figure 9. Pharmaceutical Company Case Studies

Figure 10. Biotechnology Company Case Studies

Figure 11. Others Case Studies

Figure 12. Biopharmaceutical CDMO Service Report Years Considered

Figure 13. Global Biopharmaceutical CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Biopharmaceutical CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Biopharmaceutical CDMO Service Market Share by Region: 2023 VS 2030

Figure 16. Global Biopharmaceutical CDMO Service Market Share by Players in 2023

Figure 17. Global Top Biopharmaceutical CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biopharmaceutical CDMO Service as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Biopharmaceutical CDMO Service Revenue in 2023

Figure 19. North America Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Biopharmaceutical CDMO Service Market Share by Country (2019-2030)

Figure 21. United States Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Biopharmaceutical CDMO Service Market Share by Country (2019-2030)

Figure 25. Germany Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Biopharmaceutical CDMO Service Market Share by Region (2019-2030)

Figure 33. China Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Biopharmaceutical CDMO Service Market Share by Country (2019-2030)

Figure 41. Mexico Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Biopharmaceutical CDMO Service Market Share by Country (2019-2030)

Figure 45. Turkey Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Biopharmaceutical CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. KBI Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 48. INCOG BioPharma Services Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 49. CordenPharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 50. AGC Biologics Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 51. Northway Biotech Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 52. PlantForm Corp Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 53. Lonza Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 54. ADL Biopharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 55. Catalent Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 56. Future Fields Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 57. Vetter Pharma Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 58. Stelis Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 59. Richter-Helm Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 60. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 61. Cambrex Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 62. Pfizer CentreOne Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 63. Samsung Biologics Revenue Growth Rate in Biopharmaceutical CDMO Service Business (2019-2024)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions